Estrogens, autoimmunity and the heart

Lupus

Volumn 14, Issue 9, 2005, Pages 675-678

  Cutolo, Maurizio ^a   Sulli, A ^a   Seriolo, B ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Atherosclerotic lesions; Autoimmune rheumatic diseases; Estrogens; Hormone

Indexed keywords

CONJUGATED ESTROGEN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ESTRADIOL; ESTROGEN; LIPID; LIPOPROTEIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CYTOKINE PRODUCTION; ESTROGEN ACTIVITY; ESTROGEN THERAPY; HEART PROTECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MONONUCLEAR CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; THROMBOPHILIA;

ANIMALS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASES; CLINICAL TRIALS; ESTROGENS; HEART; HORMONE REPLACEMENT THERAPY; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 26244465869     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2198oa     Document Type: Review

References (28)

1. Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD. Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 2002; 1: 338-472.
2. Meyer O. Atherosclerosis and connective tissue diseases. Joint Bone Spine 2001; 68: 564-575.
3. Seriolo B, Sulli A, Burroni A, Cutolo M. Rheumatoid arthritis and atherosclerosis. Reumatismo 2003; 55: 140-146.
4. Bacon PA, Raza K, Banks MJ, Townend J, Kitas GD. The role of endothelial cell dysfunction in the cardiovascular mortality of RA. Int Rev Immunol 2002; 21: 1-17.
5. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90-119.
6. Stork S, van der Schouw YT, Grobbee DE, Bots ML. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol Metab 2004; 15: 66-72.
7. Arnal JF, Gourdy P, Elhage R et al. Estrogens and atherosclerosis. Eur J Endocrinol 2004; 150: 113-117.
8. Elhage R, Clamens S, Besnard S et al. Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis 2001; 156: 315-322.
9. Rackley CE. Hormones and coronary atherosclerosis in women. Endocrine 2004; 24: 245-250.
10. Stevenson JC. The metabolic basis for the effects of HRT on coronary heart disease. Endocrine 2004; 24: 239-244.
11. Cutolo M, Lahita R. Etrogens and arthritis. Rheum Dis Clin North Am 2005; 31: 19-27.
12. Bijlsma JW, Cutolo M, Straub RH, Masi AT. Clinical aspects of immune neuroendocrine mechanisms in rheumatic diseases. Rheum Dis Clin North Am 2005; 31: xiii-xvi.
13. Lockshin MD. Sex ratio and rheumatic disease. Autoimmun Rev 2002; 1: 162-167.
14. Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses and autoimmune diseases: mechanisms of sex hormone action. Am J Pathol 1985; 121: 531-551.
15. Sànchez-Guerrero J, Liang MH, Karlson EW. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 1995; 122: 430-432.
16. Zhao XJ, Mckeer M, Dong Z. Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax 2001; 56: 205-211.
17. Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 1999; 103: 282-288.
18. Cutolo M, Wilder R. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am 2000; 26: 825-839.
19. Cid MC, Schnaper HW, Kleinman HK. Estrogens and the vascular endothelium. Ann N Y Acad Sci 2002; 966: 143-157.
20. Caligiuri G, Nicoletti A, Zhou X, Tomberg I, Hansson GK. Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis 1999; 145: 301-308.
21. Jara LJ, Medina G, Vera-Lastra O, Shoenfeld Y. Atherosclerosis and antiphospholipid syndrome. Clin Rev Allergy Immunol 2003; 25: 79-88.
22. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS. Testosterone as a protective factor against atherosclerosis-immunomodulation and influence upon plaque development and stability. J Endocrinol 2003; 178: 373-380.
23. Bijlsma JWJ, Straub RH, Masi AT, Lahita RG, Cutolo M. Neuroendocrine immune mechanisms in rheumatic diseases. Trends Immunol 2002; 23: 59-66.
24. Macdiarmid F, Wang D, Duncan LJ et al. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor α. Mol Cell Endocrinol 1994; 106: 17-21.
25. Purohit A, Ghilchic MW, Duncan L. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995; 80: 3052-3058.
26. Le Bail J, Liagre B, Vergne P, Bertin P, Beneytout J, Habrioux G. Aromatase in synovial cells from postmenopausal women. Steroids 2001; 66: 749-755.
27. Folomeev M, Dougados M, Beaune J et al. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1992; 1: 191-195.
28. Cutolo M, Sulli A, Capellino S et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004; 13: 635-638.